Mankind Pharma Q2FY27 net profit rises 38% YoY, EBITDA margin reaches 27.1%
Mankind Pharma reported a net profit of ₹716 crore for Q2FY27. Its EBITDA margin rose to 27.1%. Domestic business, excluding consumer healthcare, grew 15.9%. International revenue climbed 33%.
